Rezivertinib analogue 1
Based on 1 Customer Validation
Rezivertinib analogue 1 is a process impurity of osimertinib mesylate. Rezivertinib analogue 1 can be used in the study of non-small cell lung cancer.
For research use only. We do not sell to patients.
- Purity: 99.00%
- CAS No.: 2227103-37-7
- Formula: C27H33N7O2
- Molecular Weight:487.60
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Anti-Lung Cancer Compound Library
HY-L075
-
Drug Metabolite Library
HY-L098
-
Heterocyclic Compound Library
HY-L138
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
-
Metabolism/Protease Compound Library
HY-L012
-
Anti-Cancer Compound Library
HY-L025
Biological Activity
Chemical Information
-
CAS No. 2227103-37-7
-
Appearance Solid
-
Molecular Weight 487.60
-
Formula C27H33N7O2
-
Color Off-white to light yellow
-
SMILES
O=C(C)NC1=CC(NC2=NC(C3=CN(C)C4=C3C=CC=C4)=CC=N2)=C(C=C1N(CCN(C)C)C)OC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 50 mg/mL (102.54 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.0509 mL | 10.2543 mL | 20.5086 mL | 51.2715 mL |
| 5 mM | 0.4102 mL | 2.0509 mL | 4.1017 mL | 10.2543 mL | |
| 10 mM | 0.2051 mL | 1.0254 mL | 2.0509 mL | 5.1272 mL | |
| 15 mM | 0.1367 mL | 0.6836 mL | 1.3672 mL | 3.4181 mL | |
| 20 mM | 0.1025 mL | 0.5127 mL | 1.0254 mL | 2.5636 mL | |
| 25 mM | 0.0820 mL | 0.4102 mL | 0.8203 mL | 2.0509 mL | |
| 30 mM | 0.0684 mL | 0.3418 mL | 0.6836 mL | 1.7091 mL | |
| 40 mM | 0.0513 mL | 0.2564 mL | 0.5127 mL | 1.2818 mL | |
| 50 mM | 0.0410 mL | 0.2051 mL | 0.4102 mL | 1.0254 mL | |
| 60 mM | 0.0342 mL | 0.1709 mL | 0.3418 mL | 0.8545 mL | |
| 80 mM | 0.0256 mL | 0.1282 mL | 0.2564 mL | 0.6409 mL | |
| 100 mM | 0.0205 mL | 0.1025 mL | 0.2051 mL | 0.5127 mL |
Rezivertinib analogue 1 Related Classifications
HY-148053 Related Classifications
Powered by Bioz